Author

Bingwei Wang

Peking UniversityORCID 0000-0002-9306-4323Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cancer Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Changxian Xiong· 2 shared Daotong LiiD· 2 shared Jiarui LiuiD· 2 shared Ruimao ZhengiD· 2 shared Shizhang WeiiD· 2 shared Yujia Hou· 2 shared Yun ZhaoiD· 2 shared Ho Man ChaniD· 1 shared

Activity by Year

2024-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Changxian Xiong

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BioinformaticsResearchPeer-reviewedJan 1, 2025

The discovery of phages in the Substantia Nigra and its implication for Parkinson's Disease

Yun Zhao, Changxian Xiong, Bingwei Wang…·Ruimao Zheng

The paper identifies phages in the human substantia nigra and links their presence to Parkinson's Disease pathogenesis through virome analysis and gene expression correlation.

5 citations

humanbulk RNA-seq

𝕏 PostBluesky

NeurosciencebioRxivPreprintSep 13, 2024

Age-related decline of PKA-RIIβ level in SNc dopaminergic neurons underlies PD pathogenesis

Yun Zhao, Bingwei Wang, Miao Zhao…·Ruimao Zheng

The paper identifies a decline in PKA-RIIβ levels in SNc dopaminergic neurons of PD patients and shows that restoring PKA-RIIβ alleviates parkinsonism in mice.

4 citations

mousebulk RNA-seq

𝕏 PostBluesky

Cancer BiologyeLifePeer-reviewedJul 17, 2024

Repression of PRMT activities sensitize homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment

Youyou Zhang, Mu Xu, Jiao Yuan…·Xiaowen Hu

This study identifies PRMT inhibitors as effective combinational therapies with PARP inhibitors to sensitize HR-proficient ovarian and breast cancer cells to treatment.

8 citations

humanbulk RNA-seq

𝕏 PostBluesky